Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on (R) 3 amino 1 butanol. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN116515782A reveals a novel amine dehydrogenase mutant for high-purity chiral amine alcohol production, offering significant cost and safety advantages.
Novel biocatalytic method for (S)-2-amino-1-butanol and (R)-3-amino-1-butanol using amine dehydrogenases. High yield, mild conditions, scalable process for pharmaceutical intermediates.